Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03226262 · ClinicalTrials.gov registry record
FFRangio Accuracy vs. Standard FFR
A clinical trial, sponsored by CathWorks.
- Completed
- Registry status
- 382
- Enrollment target
NCT03226262: Completed study, sponsored by CathWorks.
NCT03226262 is a clinical trial that has completed, run by CathWorks. The registered enrollment target is 382 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03226262 has completed, sponsored by CathWorks.
- COMPLETED
- Registry status
- 382 participants
- Enrollment target
Study Summary
This is a prospective, observational, multi-center, single-arm, clinical trial designed to assess the efficacy of FFRangio in measuring FFR obtained from angiography compared to Invasive FFR for diagnosing hemodynamically significant coronary stenosis.
Primary Outcome
Sensitivity and specificity of the dichotomously scored FFRangio measured index per vessel as compared with invasively-derived FFR; Index ≤ 0.80 is scored "positive" while Index \> 0.8 is negative.
Interventions
- DEVICE FFRangio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2017-09-27 |
| Est. Completion | 2018-06-08 |
What the finished NCT03226262 record still lists
NCT03226262 is an observational study that tracks outcomes without assigning an intervention. The registered 382 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which FFRangio is the first listed.
NCT03226262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03226262 about?
NCT03226262 is a clinical study titled "FFRangio Accuracy vs. Standard FFR". This is a prospective, observational, multi-center, single-arm, clinical trial designed to assess the efficacy of FFRangio in measuring FFR obtained from angiography compared to Invasive FFR for diagnosing hemodynamically significant coronary stenosis.
What is the current status of trial NCT03226262?
This trial is currently completed. The enrollment target is 382 participants. The study started on 2017-09-27. Estimated completion is 2018-06-08.
What interventions are being tested in trial NCT03226262?
The interventions under investigation include: FFRangio (DEVICE).
Who is sponsoring clinical trial NCT03226262?
This trial is sponsored by CathWorks, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI